Urogenital tuberculosis

From Food & Medicine Encyclopedia


Urogenital tuberculosis
Synonyms Genitourinary tuberculosis
Pronounce N/A
Specialty N/A
Symptoms Dysuria, hematuria, flank pain, fever, weight loss
Complications Kidney failure, infertility, ureteral stricture
Onset Variable, often months to years after initial infection
Duration Chronic
Types N/A
Causes Mycobacterium tuberculosis infection
Risks HIV/AIDS, immunosuppression, diabetes mellitus
Diagnosis Urine culture, imaging studies, tuberculin skin test, interferon-gamma release assays
Differential diagnosis Urinary tract infection, renal cell carcinoma, interstitial cystitis
Prevention N/A
Treatment Antitubercular therapy (e.g., isoniazid, rifampicin, ethambutol, pyrazinamide)
Medication Antibiotics
Prognosis N/A
Frequency Rare in developed countries, more common in regions with high tuberculosis prevalence
Deaths Rare with treatment, but can be fatal if untreated


Urogenital Tuberculosis[edit]

Urogenital tuberculosis is a form of tuberculosis that affects the urinary system and the genital organs. It is a type of extrapulmonary tuberculosis, which means it occurs outside the lungs. This condition is caused by the bacterium Mycobacterium tuberculosis, the same organism responsible for pulmonary tuberculosis.

Pathophysiology[edit]

Urogenital tuberculosis typically begins as a hematogenous spread from a primary infection site, often the lungs. The bacteria can lodge in the kidneys, which are the most common site of infection in the urogenital tract. From the kidneys, the infection can spread to the ureters, bladder, and urethra. In men, it can also affect the prostate gland, seminal vesicles, and epididymis. In women, the fallopian tubes and endometrium may be involved.

Symptoms[edit]

The symptoms of urogenital tuberculosis can vary depending on the organs involved. Common symptoms include:

Diagnosis[edit]

Diagnosis of urogenital tuberculosis can be challenging due to its nonspecific symptoms. It often requires a combination of:

Treatment[edit]

The treatment of urogenital tuberculosis involves a prolonged course of antitubercular therapy (ATT), which typically includes a combination of drugs such as isoniazid, rifampicin, ethambutol, and pyrazinamide. The duration of treatment is usually 6 to 9 months, but it may be extended in complicated cases.

Prognosis[edit]

With appropriate treatment, the prognosis for urogenital tuberculosis is generally good. However, delayed diagnosis and treatment can lead to complications such as renal failure, ureteral strictures, and infertility.

Related pages[edit]

References[edit]

  • World Health Organization. (2021). "Tuberculosis Fact Sheet." Retrieved from [1]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.